BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32893112)

  • 21. Effectiveness of Lung-RADS in Reducing False-Positive Results in a Diverse, Underserved, Urban Lung Cancer Screening Cohort.
    Kaminetzky M; Milch HS; Shmukler A; Kessler A; Peng R; Mardakhaev E; Bellin EY; Levsky JM; Haramati LB
    J Am Coll Radiol; 2019 Apr; 16(4 Pt A):419-426. PubMed ID: 30146484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
    Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
    Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration.
    Lillie SE; Fu SS; Fabbrini AE; Rice KL; Clothier B; Nelson DB; Doro EA; Moughrabieh MA; Partin MR
    Lung Cancer; 2017 Feb; 104():38-44. PubMed ID: 28212998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Positive and Suspicious Findings in Clinical Computed Tomography Lung Cancer Screening and the Road Ahead.
    Regis SM; Borondy-Kitts A; McKee AB; Rieger-Christ K; Sands J; Afnan J; McKee BJ
    Ann Am Thorac Soc; 2022 Aug; 19(8):1371-1378. PubMed ID: 34818144
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
    Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
    Erkmen CP; Dako F; Moore R; Dass C; Weiner MG; Kaiser LR; Ma GX
    Cancer Causes Control; 2021 Mar; 32(3):291-298. PubMed ID: 33394208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung CAncer SCreening in French women using low-dose CT and Artificial intelligence for DEtection: the CASCADE study protocol.
    Revel MP; Abdoul H; Chassagnon G; Canniff E; Durand-Zaleski I; Wislez M
    BMJ Open; 2022 Dec; 12(12):e067263. PubMed ID: 36600392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Computed Tomography Radiation Doses Used for Lung Cancer Screening Scans.
    Demb J; Chu P; Yu S; Whitebird R; Solberg L; Miglioretti DL; Smith-Bindman R
    JAMA Intern Med; 2019 Dec; 179(12):1650-1657. PubMed ID: 31545340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoting lung cancer screening of high-risk patients by primary care providers.
    Colamonici M; Khouzam N; Dell C; Auge-Bronersky K; Pacheco E; Rubinstein I; Recht B
    Cancer; 2023 Nov; 129(22):3574-3581. PubMed ID: 37449669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observer variability for Lung-RADS categorisation of lung cancer screening CTs: impact on patient management.
    van Riel SJ; Jacobs C; Scholten ET; Wittenberg R; Winkler Wille MM; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
    Eur Radiol; 2019 Feb; 29(2):924-931. PubMed ID: 30066248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to Annual Lung Cancer Screening in a Centralized Academic Program.
    Lee G; Hill LP; Schroeder MC; Kraus SJ; El-Abiad KMB; Hoffman RM
    Clin Lung Cancer; 2024 Jan; 25(1):e18-e25. PubMed ID: 37925362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U.S. Newspaper Coverage of Lung Cancer Screening From 2010 to 2022.
    Zippi ZD; Cortopassi IO; Johnson EM; McDermott S; Mergo PJ; Petranovic M; Price MC; Stowell JT; Little BP
    AJR Am J Roentgenol; 2023 Aug; 221(2):258-271. PubMed ID: 36919884
    [No Abstract]   [Full Text] [Related]  

  • 36. Invasive Procedures Associated With Lung Cancer Screening in Clinical Practice.
    Manyak A; Seaburg L; Bohreer K; Kirtland SH; Hubka M; Gerbino AJ
    Chest; 2023 Aug; 164(2):544-555. PubMed ID: 36781101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.
    Pinsky PF; Bellinger CR; Miller DP
    J Med Screen; 2018 Jun; 25(2):110-112. PubMed ID: 28929865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
    Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
    J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort.
    Kessler A; Peng R; Mardakhaev E; Haramati LB; White CS
    Radiol Imaging Cancer; 2020 Mar; 2(2):e190021. PubMed ID: 33778703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.
    Mets OM; Schmidt M; Buckens CF; Gondrie MJ; Isgum I; Oudkerk M; Vliegenthart R; de Koning HJ; van der Aalst CM; Prokop M; Lammers JW; Zanen P; Mohamed Hoesein FA; Mali WP; van Ginneken B; van Rikxoort EM; de Jong PA
    Respir Res; 2013 May; 14(1):59. PubMed ID: 23711184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.